Christian K Schneider, M.D., is Chief Medical Officer, Strategic Product Development Consulting, and Vice President & Head of Biopharma Excellence at PharmaLex. Before joining PharmaLex, Christian was interim Chief Scientific Officer at the UK’s medical products regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). Before that, he was Director of the National Institute for Biological Standards and Control (NIBSC), an agency within the MHRA.  

Christian has broad global regulatory authority experience, having served as Medical Head of Division Medicines Licensing & Availability at the Danish Medicines Agency and as Head of Division EU Cooperation/Microbiology at the Paul-Ehrlich-Institut, Germany’s Federal Agency for Vaccines and Biomedicines. Christian has also held various senior delegate roles at the European Medicines Agency (EMA), including as Chair of the EMA’s Committee for Advanced Therapies (CAT) and member of the EMA’s Committee for Medicinal Products for Human Use (CHMP). He also was Chair of the EMA’s Biosimilar Medicinal Products Working Party (BMWP) for nine years and was one of the key architects of the agency’s advanced therapies and biosimilars framework. As a regulatory scientist, he has published more than 50 articles in international peer-reviewed journals.